- Hepatocellular carcinoma in body builders; an emerging rare but serious complication of androgenic anabolic steroid use
-
Woodward C, Smith J, Acreman D, Kumar N
- KMID: 2448772
- Ann Hepatobiliary Pancreat Surg.
- 2019 May;23(2):174-177.
- doi: 10.14701/ahbps.2019.23.2.174
Illicit use of androgenic anabolic steroids (AAS) is a known problem amongst certain groups including body builders and other athletes. Use of these drugs is thought to be high in... -
- CITED
-
- Close
- SHARE
-
- Close
- Changes of Somatotypes and Body Proportions in Korean Youths
-
Lee Y
- KMID: 2071853
- Korean J Phys Anthropol.
- 1999 Jun;12(1):175-186.
The aim of the present study is to try to quantify the changes in somatotypes and to determine, if any, the distinctive features of young Koreans while they are growing.... -
- CITED
-
- Close
- SHARE
-
- Close
- Usefulness of Somatotype Drawing as an Instrument of Recalling Obesity in High School Girls
-
Bae JM
- KMID: 2304059
- Korean J Epidemiol.
- 1997 Dec;19(2):147-151.
INTRODUCTION: The obesity is related to the chronic diseases of adults. The measurement of obesity level in adolescence is recommended by using Body Mass Index (BMI), but there is a... -
- CITED
-
- Close
- SHARE
-
- Close
- Correlation of Somatotype Drawing and Anthropometric Values
-
Jeong YS, Park EW, Bae JM, Lee Y
- KMID: 2056330
- J Korean Acad Fam Med.
- 1997 Sep;18(9):918-926.
BACKGROUND: The evaluation of obesity in practice has been done indirectly by anthropometric values such as body mass index(BMI), waist and hip circumferences and waisthip ratio(WHR). Somatotype drawing developed by... -
- CITED
-
- Close
- SHARE
-
- Close
- Usefulness of Somatotype Drawing as a Instrument of Measuring Obesity Level in Korea
-
Bae JM, Ahn YO
- KMID: 2304091
- Korean J Epidemiol.
- 1996 Jun;18(1):101-107.
BACKGROUND: As modern epidemiologic studies began to identify obesity as a risk factor for cardiovascular disease, diabetes, hypertension, and cancer, measuring the degree of excess body fat is important on... -
- CITED
-
- Close
- SHARE
-
- Close
